Atrial Fibrillation: A Review of Recent Studies with a Focus on Those from the Duke Clinical Research Institute

<table>Duke Databank. Warfarin use at discharge among patients with coronary artery disease according to CHADS2 (stroke) and ATRIA (bleeding) scores in patients 65 to 79 versus ≥80 years of age [<a href="/journals/scientifica/2014/901586/#B25">25</a>].</table>

Scientifica

fig2

Figure 2

Figure 2: Atrial Fibrillation: A Review of Recent Studies with a Focus on Those from the Duke Clinical Research Institute 